SEC Form 4 · accession 0001179110-17-003722
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clive Meanwell
Officer — CEO · Director
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 7:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 28, 2017 | A | 320 | $33.12 | A | 379,488 | D | |
| Common StockF2 | Mar 1, 2017 | A | 34,156 | $0.00 | A | 413,644 | D | |
| Common StockF3 | Mar 2, 2017 | F | 27,149 | $52.40 | D | 386,495 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right-to-buy)F4 | $52.70 | Mar 1, 2017 | A | 210,793 | A | — | Mar 1, 2027 | Common Stock | 210,793 | 210,793 | D |
Explanation of responses
- F1Shares of common stock acquired pursuant to The Medicines Company Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period beginning September 1, 2016 and ending February 28, 2017. In accordance with the terms of the ESPP, these shares were purchased based on 85% of the fair market value closing price of the issuer's common stock on September 1, 2016.
- F2Shares of restricted stock vest in 25% increments on each anniversary of the date of grant, until fully vested.
- F3Shares of common stock were withheld for payment of taxes in connection with the vesting of 52,484 shares of restricted stock from previously reported grants.
- F4The option vests in forty-eight equal installments beginning April 1, 2017.